Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...
GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
GLP-1 medications, like Ozempic and Wegovy, mimic natural hormones in the body that regulate blood sugar and insulin levels. They’re used to treat type 2 diabetes and obesity. These drugs curb the ...
A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...
As open enrollment kicks off, employees may find an unpleasant surprise in their 2025 health insurance premiums. Increased adoption of GLP-1 drugs, rising catastrophic claims and other cost pressures ...